Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y9XD
|
||||
Former ID |
DIB005160
|
||||
Drug Name |
Dalvastatin
|
||||
Synonyms |
RG-12561
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Discontinued in Phase 3 | [545019] | ||
Company |
Rhone-Poulenc SA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H31FO3
|
||||
Canonical SMILES |
C1(=C(c2cc(c(cc2)F)C)CC(CC1(C)C)(C)C)/C=C/[C@H]1OC(=O)C<br />[C@@H](C1)O
|
||||
CAS Number |
CAS 132100-55-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Target Info | Inhibitor | [534036] | |
PANTHER Pathway | Cholesterol biosynthesis | ||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.